Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
162M
-
Number of holders
-
151
-
Total 13F shares, excl. options
-
146M
-
Shares change
-
-8.78M
-
Total reported value, excl. options
-
$105M
-
Value change
-
-$20M
-
Put/Call ratio
-
0
-
Number of buys
-
77
-
Number of sells
-
-116
-
Price
-
$0.72
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q2 2025
221 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q2 2025.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 151 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 146M shares
of 162M outstanding shares and own 90.41% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (16.2M shares), ARMISTICE CAPITAL, LLC (16.2M shares), Sarissa Capital Management LP (15.9M shares), BlackRock, Inc. (12M shares), RENAISSANCE TECHNOLOGIES LLC (8.41M shares), ACADIAN ASSET MANAGEMENT LLC (6.55M shares), AQR CAPITAL MANAGEMENT LLC (6.17M shares), Kynam Capital Management, LP (5.47M shares), MARSHALL WACE, LLP (3.99M shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (3.66M shares).
This table shows the top 151 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.